Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC accept Competact

The Scottish Medicines Consortium has accepted the combination product containing metformin 850mg and pioglitazone 15mg (Competact®) for use in Type II Diabetes on the NHS in Scotland.

The advice document states that the product is cost equivalent to separate preparations and may therefore offer a more convenient, if less flexible, dosing regimen.

Pragmatically, reducing the number of tablets taken will have a beneficial effect upon compliance. In practice, individuals who are likely to be prescribed this medicine are likely to be on several other agents including antiplatelets, statins and antihypertensives. Substituting this product may not have a dramatic impact in this instance.

Action: This product is an option when compliance is a known issue. Using concordant approach when initiating prescriptions to provide patients with information about the benefits and risks of treatment is also likely to aid future compliance.

Share 'SMC accept Competact' on Email Share 'SMC accept Competact' on Delicious Share 'SMC accept Competact' on Digg Share 'SMC accept Competact' on Facebook Share 'SMC accept Competact' on Google+ Share 'SMC accept Competact' on reddit Share 'SMC accept Competact' on StumbleUpon Share 'SMC accept Competact' on Twitter

atomic-wealth

No Comments to “SMC accept Competact”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,518 spam comments.

atomic-wealth
fond-illness
summer